CymaBay Therapeutics, Inc.
Industry: Life Sciences ・ $CBAY on Nasdaq
Insider Sale
+$117,900
-100%
Shares
Shares Volume: 5,000 Shares
Average Share Price: $23.58
INSIDER
Quinlan Paul T
General Counsel (Officer)
reported on Jan 16 2024
traded on Jan 16 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
NEW SHARES OWNERSHIP AMOUNT
0
PURCHASES/SALES 1Y0 / 8
P/S VALUE RATION/A
AVERAGE SALE VALUE$178,688.75
INSIDER PREVIOUS TRADES
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS
with at least one purchase / sale
0 / 2
PURCHASES/SALES 1Y0 / 29
P/S VALUE RATION/A
AVERAGE SALE VALUE$304,975.1
COMPANY PREVIOUS TRADES
Get Feature Updates
Subscribe to our newsletter and receive the latest updates. You will get pre-access to new features